ALB — Albemarle Income Statement
0.000.00%
- $6.79bn
- $11.59bn
- $5.38bn
- 30
- 62
- 12
- 26
Annual income statement for Albemarle, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,129 | 3,328 | 7,320 | 9,617 | 5,378 |
Cost of Revenue | |||||
Gross Profit | 997 | 1,008 | 3,078 | 1,197 | 63.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,639 | 2,534 | 4,851 | 9,363 | 7,160 |
Operating Profit | 490 | 794 | 2,469 | 255 | -1,782 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 374 | 134 | 2,433 | 247 | -1,764 |
Provision for Income Taxes | |||||
Net Income After Taxes | 319 | 104 | 2,043 | -184 | -1,851 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 376 | 124 | 2,690 | 1,573 | -1,179 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 376 | 124 | 2,690 | 1,573 | -1,316 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.16 | -0.813 | 22.7 | 14.4 | -5.11 |
Dividends per Share |